EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Indoxyl Sulfate, a Gut Microbiota-Derived Metabolite, Modulates Hepatic Cholesterol Metabolism via SREBP-2/HMG-CoA Reductase Upregulation in Rats

Mateusz Szudzik, Mikołaj Zajdel iD, Anna Laskowska, Tomasz Hutsch, Marcin Ufnal iD

Nutrients · 03.07.2026 · 18 (13) · 2160

DOI: 10.3390/nu18132160 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, online erschienen am 03.07.2026. Verfasst von Mateusz Szudzik und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Centre for Preclinical Research, Department of Experimental Physiology and Pathophysiology, Medical University of Warsaw, Pawińskiego 3…. Hauptthemen laut MEDLINE: Sterol Regulatory Element Binding Protein 2, Liver, Indican, Cholesterol. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Warsaw.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

A high-fat diet (HFD) contributes to cardiometabolic disease. Gut microbiota-derived metabolites may participate in this process, but their contribution to lipid regulation is not well defined. Indoxyl sulfate (IS), a microbiota-derived metabolite, has been linked to vascular and metabolic dysfunction. Its role in lipid metabolism remains unclear.

Methods

In Part A, plasma and urinary concentrations of IS were measured in plasma and urine from HFD-fed rats in which dyslipidemia had developed, together with controls. In Part B, HepG2 cells were exposed to IS, and cell viability and selected cholesterol metabolism-related transcripts and proteins were assessed. In Part C, 10-week-old, male Sprague–Dawley rats maintained on a standard diet received vehicle or IS at two doses for 8 weeks. Hepatic expression of LDLR, SREBP-2, HMG-CoA reductase, and related cholesterol metabolism markers were measured by quantitative real-time PCR and Western blotting.

Results

In Part A, higher plasma IS concentrations and higher daily urinary IS excretion were found in samples collected from HFD-fed rats compared to controls. In HepG2 cells, IS reduced cell viability at higher concentrations and increased LDLR mRNA and protein expression. In IS-treated rats, total cholesterol, LDL-cholesterol, and triglycerides increased in a dose-dependent manner. Hepatic SREBP-2 and HMG-CoA reductase protein levels were increased at both IS doses, whereas LDLR protein abundance was increased at the higher dose. Moreover, serum PCSK9 levels were reduced in IS-treated rats.

Conclusion

IS increased in HFD-fed rats. IS altered cholesterol metabolism-related pathways in HepG2 cells and in rats. In vivo IS administration increased circulating lipids and hepatic proteins involved in cholesterol synthesis and uptake. These findings indicate that IS may contribute to disturbed lipid homeostasis, although its role in HFD-induced dyslipidemia requires further mechanistic confirmation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sterol Regulatory Element Binding Protein 2LiverIndicanCholesterolGastrointestinal MicrobiomeHydroxymethylglutaryl CoA ReductasesAnimalsMaleRats, Sprague-DawleyHep G2 CellsHumansUp-RegulationDiet, High-FatRatsDyslipidemiasLipid MetabolismSterol Regulatory Element Binding Proteins

Stichwörter der Autor:innen

LDLbacterial metabolitesdyslipidemiaindoxyl sulfate

Substanzen

Sterol Regulatory Element Binding Protein 2IndicanCholesterolHydroxymethylglutaryl CoA ReductasesSrebf2 protein, ratSterol Regulatory Element Binding Proteins

Autor:innen und Institutionen

  • Laboratory of Centre for Preclinical Research, Department of Experimental Physiology and Pathophysiology, Medical University of Warsaw, Pawińskiego 3c Street, 02-091 Warsaw, Poland.
  • Centre for Preclinical Research and Technology (CePT), Department of Pharmaceutical Microbiology and Bioanalysis, Faculty of Pharmacy, Medical University of Warsaw, 02-097 Warsaw, Poland.
  • Department of Pathology and Veterinary Diagnostics, Institute of Veterinary Medicine, Warsaw University of Life Sciences, 02-776 Warsaw, Poland.

ORCID-Profile: Mikołaj Zajdel, Marcin Ufnal

Förderung

  • Medical University of Warsaw

Zitieren

APA

Szudzik, M., Zajdel, M., Laskowska, A., Hutsch, T., & Ufnal, M. (2026). Indoxyl Sulfate, a Gut Microbiota-Derived Metabolite, Modulates Hepatic Cholesterol Metabolism via SREBP-2/HMG-CoA Reductase Upregulation in Rats. Nutrients, 18(13), 2160. https://doi.org/10.3390/nu18132160

Vancouver

Szudzik M, Zajdel M, Laskowska A, Hutsch T, Ufnal M. Indoxyl Sulfate, a Gut Microbiota-Derived Metabolite, Modulates Hepatic Cholesterol Metabolism via SREBP-2/HMG-CoA Reductase Upregulation in Rats. Nutrients. 2026;18(13):2160. doi:10.3390/nu18132160

BibTeX
@article{Szudzik2026,
  author = {Szudzik, Mateusz and Zajdel, Mikołaj and Laskowska, Anna and Hutsch, Tomasz and Ufnal, Marcin},
  title = {Indoxyl Sulfate, a Gut Microbiota-Derived Metabolite, Modulates Hepatic Cholesterol Metabolism via SREBP-2/HMG-CoA Reductase Upregulation in Rats},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {13},
  pages = {2160},
  doi = {10.3390/nu18132160}
}
Kostenlos starten →